The mission of the Alzheimer’s Association Business Consortium (AABC) is to advance Alzheimer’s disease and dementia research through innovation in small- and medium-size biotechnology, diagnostics, medical device and contract research organizations.

AABC members work in areas of common interest pre-competitively to advance both the field of dementia research and the goals of its member organizations. They provide leadership and direction to the group’s areas of focus, which include, but are not limited to, collaborations, recognition and visibility, and knowledge and information sharing.

Collaborations

Collaborations are essential to companies as a way to share resources, expand infrastructure, save money and potentially create income. The consortium will provide a platform for companies looking for collaboration opportunities between member companies and enhance collaborations with large companies and other institutions external to the consortium.

Recognition and visibility

Companies will benefit from publications and positive publicity. As such, the AABC will look for ways to bring companies in this sector to the attention of the Alzheimer's Disease and Related Dementias community through publications, presentations and posters.

Knowledge and information sharing

The AABC will look for ways to share knowledge and information in a pre-competitive space. The group will share information about each member company. They may also share information on trusted consultants, CRO’s, ways to manage data in a small company, funding strategies and funding sources.

Consortium members

AI

Diagnostics

Therapeutics

Other

AABC webinars

AABC AAIC Meeting - July 2024 (Video | Passcode: 23%%FuH8)
Federal Grant Funding - March 2023 (Video | Passcode: e@MgG0h%)
Federal Grant Funding - March 2023 (PDF)
Leveraging SBIR/STTR to Advance Alzheimer’s and Aging Innovations (Video)
Leveraging SBIR/STTR to Advance Alzheimer’s and Aging Innovations (PDF)
Ask the Expert: CEO Panel - April 2019 (Video)

Newsletters

Publications

Translational animal models for Alzheimer's disease: An Alzheimer's Association Business Consortium Think Tank, Alzheimer’s Dementia: Translational Research & Clinical Interventions (TRCI) 

Maximizing the Potential of Small Companies in Alzheimer’s Disease Research: Challenges and Opportunities (PPT)

Past events

The AABC Translation Animal Models Group, chaired by Joseph Araujo, InterVivo Solutions, and facilitated by Rebecca Edelmayer, Alzheimer’s Association, in collaboration with MODEL-AD members held a think tank in Washington, D.C., Nov. 28-29, 2018. The think tank was a shoulder meeting to the Alzheimer’s Association Research Roundtable and was well attended. The agenda consisted of sessions addressing proteomics, genomics and metabolomics, modern behavioral models, and translational, experimental and operational issues. The think tank proceedings will be submitted for publication. View the guest logistics or agenda for more information.

Get more information

The AABC welcomes new members who are aligned in its commitment to research and innovation. To express interest in joining, email Theresa Devins, chair; Paul Slowey, co-chair; or Christopher Weber, Ph.D., facilitator.

For more information on the AABC, contact:

Christopher Weber, Ph.D.
Sr. Director, Global Science Initiatives
Medical & Scientific Relations
Alzheimer's Association
cweber@alz.org